- Home
- SYRE vs BRKL Comparison
SYRE vs BRKL Comparison
Compare SYRE & BRKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRE
- BRKL
- Stock Information
- Founded
- SYRE 2013
- BRKL 1871
- Country
- SYRE United States
- BRKL United States
- Employees
- SYRE N/A
- BRKL N/A
- Industry
- SYRE Biotechnology: Pharmaceutical Preparations
- BRKL Savings Institutions
- Sector
- SYRE Health Care
- BRKL Finance
- Exchange
- SYRE Nasdaq
- BRKL Nasdaq
- Market Cap
- SYRE 841.4M
- BRKL 897.3M
- IPO Year
- SYRE 2016
- BRKL 1998
- Fundamental
- Price
- SYRE $15.30
- BRKL $10.33
- Analyst Decision
- SYRE Buy
- BRKL Buy
- Analyst Count
- SYRE 6
- BRKL 2
- Target Price
- SYRE $55.00
- BRKL $15.25
- AVG Volume (30 Days)
- SYRE 490.0K
- BRKL 485.2K
- Earning Date
- SYRE 05-08-2025
- BRKL 07-23-2025
- Dividend Yield
- SYRE N/A
- BRKL 5.22%
- EPS Growth
- SYRE N/A
- BRKL N/A
- EPS
- SYRE N/A
- BRKL 0.82
- Revenue
- SYRE N/A
- BRKL $338,567,000.00
- Revenue This Year
- SYRE N/A
- BRKL $53.95
- Revenue Next Year
- SYRE N/A
- BRKL $37.82
- P/E Ratio
- SYRE N/A
- BRKL $12.60
- Revenue Growth
- SYRE N/A
- BRKL N/A
- 52 Week Low
- SYRE $10.91
- BRKL $8.01
- 52 Week High
- SYRE $40.26
- BRKL $13.15
- Technical
- Relative Strength Index (RSI)
- SYRE 51.16
- BRKL 43.33
- Support Level
- SYRE $14.87
- BRKL $10.32
- Resistance Level
- SYRE $15.71
- BRKL $10.63
- Average True Range (ATR)
- SYRE 0.72
- BRKL 0.22
- MACD
- SYRE 0.10
- BRKL -0.06
- Stochastic Oscillator
- SYRE 51.57
- BRKL 12.50
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About BRKL Brookline Bancorp Inc.
Brookline Bancorp Inc operates as a multi-bank holding company. It offers commercial, business, and retail banking services, including a full complement of cash management products, online banking services, and consumer and residential loans.